Companies / Belgium

Pharmacies Toe Line Over Generic Prescribing

May 2007 | Industry News

Printable version
Bookmark

Doctors in Belgium are largely keeping in line with government targets for prescribing generic medicines, according to national health insurer Inami. As a result,

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles

UCB To Exit Primary Care Market

Industry / Belgium Drugmaker UCB has announced that it is to exit the US's primary care market in March 2010 in order to accelerate its US transition to a purely specialty-focused biopharmaceutical company. The transition...

February 2010

Galapagos Continues Alliances With Top Pharma

Industry / Belgium Announcing its second major deal in six months, Belgian biotech company Galapagos has entered a research agreement with multinational drug company Roche - a transaction that could earn the development...

January 2010

Omega Pharma Sells Aresus Stake To Focus On OTC Drug Market

Industry / Belgium Continuing with its aim of strengthening its core over-the-counter (OTC) medicines business, Belgium-based Omega Pharma has agreed to sell its remaining 24.0% stake in medical devices company Arseus...

November 2009

Drug Market Growth To Slow

Industry / Belgium Growth in the Belgian drug market is expected to decline in 2009, with pharmaceutical expenditure calculated to increase by only 2.41% by the end of this year, compared with the 5.16% and 5.23% rates...

November 2009

Galapagos Extends Its Alliance With Merck & Co

Industry / Belgium Belgian biotech company Galapagos has strengthened its alliance with Merck & Co. by signing its third deal this year with the multinational drugmaker. In January 2009, Galapagos announced an alliance...

October 2009